cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. It owns and operates consumer hemp-based CBD brands, such as cbdMD and Paw CBD. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce Website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.
IPO Year: 2017
Exchange: AMEX
Website: cbdmd.com
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
3 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Cantor Fitzgerald resumed coverage of cbdMD with a rating of Neutral and set a new price target of $3.25 from $4.10 previously
Cantor Fitzgerald reiterated coverage of cbdMD with a rating of Neutral and set a new price target of $4.30 from $3.60 previously
Fastest customizable press release news feed in the world
CHARLOTTE, N.C., Feb. 2, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading innovator in wellness and hemp-derived consumer products, today announced a major distribution expansion for its Herbal Oasis THC-infused social seltzer ("Oasis") through an expanded partnership with Morales Beverage Group ("MBG"). The agreement extends Oasis into Louisiana, strengthening the brand's regional footprint across the Gulf South and creating a more contiguous platform for continued Southeast growth, following strong early performance in Texas. With MBG's established statewide distribut
CHARLOTTE, N.C., Jan. 29, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading innovator in hemp-derived wellness products, today announced a strategic initiative to integrate and expand its regulatory science, safety, and intellectual property assets to establish a differentiated cannabinoid compliance and evidence platform aligned with evolving federal healthcare evaluation frameworks, including emerging CMS and CMMI innovation initiatives. The program combines scientific and regulatory assets acquired through cbdMD's recent acquisition of Bluebird Botanicals ("Bluebird")
CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ -- cbdMD, Inc (NYSE:YCBD), a leading innovator in hemp-derived wellness products, announced today the closing of the acquisition of substantially all of the assets of Bluebird Botanicals, one of the longest-standing brands in the CBD industry, providing an established and complementary revenue base to strengthen cbdMD's long-term growth strategy. The transaction was completed through an asset purchase comprised of an initial share issuance and earnout shares. For more details, including specific terms and conditions, please see the
CHARLOTTE, N.C., Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with hemp derived THC beverage line Herbal Oasis today announced our financial results for the full fiscal year ended September 30, 2025. For fiscal year 2025, cbdMD delivered its third consecutive year of operational and financial improvement, reflecting disciplined cost management, focused execution, and continued investment in quality and science. The Company
CHARLOTTE, N.C., Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading wellness company and the parent of Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, today announces that it has entered into securities purchase agreements with institutional investors whereby Company issued the investors an aggregate of 1,000,000 shares of Series C Convertible Preferred Stock in consideration of gross proceeds to the Company of $2.25 million. The Company intends to use the net proceeds of approximately $2.1 million for working capital general corporate purposes and support ongoing strategic initiatives. The Series C shares have a 10% annual dividend and are convert
CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Friday, December 19, 2025, to discuss the company's September 30, 2025 fourth quarter and fiscal year 2025 financial results and business progress. CONFERENCE CALL DETAILS Friday, December 19, 2025, 4:20 p.m. Eastern Time USA/Canada: 888-880-3330 Webcast/Webcast Replay link - available through December 19, 2026: https://app.webinar.net/13voDmbBl
CHARLOTTE, N.C., Dec. 8, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading innovator in wellness and hemp-derived products, is pleased to announce that it has regained full compliance with the continued listing standards of the NYSE American. As a result, the ".BC" indicator has been removed from the list of noncompliant issuers effective at the open of trading, December 8, 2025. The NYSE American formally notified the Company in a letter dated December 5, 2025, confirming that cbdMD has resolved all deficiencies related to Sections 1003(a)(i) and (ii) of the NYSE Americ
Year Over Year Net Sales Expected to Remain in line with Prior Year Year Over Year Quarterly Net Sales Expected to Increase Between 3% and 5% CHARLOTTE, N.C., Nov. 21, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD) (the "Company") one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehensive line of domestically produced CBD products and Farm Bill-compliant Delta-9 offerings, today reported the following preliminary financial results for the fourth quarter of fiscal 2025 and the year ended September 30, 2025. Net sales revenue for fisc
CHARLOTTE, N.C., Oct. 9, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehensive line of domestically produced CBD products and Farm Bill–compliant Delta-9 offerings, today announced that its Herbal Oasis hemp-derived THC-infused social seltzer, designed to redefine how people connect, unwind, and celebrate life, has expanded distribution throughout most of Florida through a new partnership with Bevtalk Distribution, a leading distributor specializing in innovative beverage brands.
Charlotte, North Carolina--(Newsfile Corp. - October 1, 2025) - cbdMD, Inc. (NYSE:YCBD), a leading wellness company and the parent of Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, today announces that it has entered into a securities purchase agreement with institutional investors including C/M Capital Master Fund, LP (the "Investors") whereby Company issued the Investors a Series B Convertible Preferred Stock (the "Shares") in consideration of gross proceeds to the Company of $1.7 million. The Company intends to use the net proceeds of $1.5 million for working capital general corporate purposes and support ongoing strategic initiatives. "We are pleased to con
PRE 14A - cbdMD, Inc. (0001644903) (Filer)
S-1 - cbdMD, Inc. (0001644903) (Filer)
10-K/A - cbdMD, Inc. (0001644903) (Filer)
424B3 - cbdMD, Inc. (0001644903) (Filer)
EFFECT - cbdMD, Inc. (0001644903) (Filer)
8-K - cbdMD, Inc. (0001644903) (Filer)
EFFECT - cbdMD, Inc. (0001644903) (Filer)
424B4 - cbdMD, Inc. (0001644903) (Filer)
S-1/A - cbdMD, Inc. (0001644903) (Filer)
10-K - cbdMD, Inc. (0001644903) (Filer)
Live finance-specific insights
CHARLOTTE, N.C., Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with hemp derived THC beverage line Herbal Oasis today announced our financial results for the full fiscal year ended September 30, 2025. For fiscal year 2025, cbdMD delivered its third consecutive year of operational and financial improvement, reflecting disciplined cost management, focused execution, and continued investment in quality and science. The Company
CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Friday, December 19, 2025, to discuss the company's September 30, 2025 fourth quarter and fiscal year 2025 financial results and business progress. CONFERENCE CALL DETAILS Friday, December 19, 2025, 4:20 p.m. Eastern Time USA/Canada: 888-880-3330 Webcast/Webcast Replay link - available through December 19, 2026: https://app.webinar.net/13voDmbBl
Announces Oasis Expands into Multiple New StatesCharlotte, North Carolina--(Newsfile Corp. - August 14, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the third quarter of fiscal year ended September 30, 2025. The Company delivered $4.6 million in revenue for the third quarter, down from $5.2 million in the prior year period. Operating loss increased from $0.4 million to $0.9 million. "While our third quarter results were not up to our standard, we have completed a major overhaul to our marketing team and dig
Charlotte, North Carolina--(Newsfile Corp. - August 12, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 14, 2025, to discuss the company's June 30, 2025 third quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, August 14, 2025, 4:20 p.m. Eastern Time USA/Canada: 833-821-3524 International: 647-846-2919 Teleconference Replay dial in: USA/Canada: 855-669-9658 International: 412-317-0088 Replay Passcode: 5327882 Webcast/Webcast Replay link - available through August 15, 20
Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter of fiscal year ended September 30, 2025. The Company reported continued year-over-year improvements in both revenue and earnings while completing a transformative restructuring of its capital structure.The Company delivered $4.8 million in revenue for the second quarter, up from $4.3 million in the prior year peri
Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, May 15, 2025, 4:20 p.m. Eastern Time USA/Canada:833-821-3524 International:647-846-2919 Teleconference Replay dial in: USA/Canada:855-669-9658 International:412-317-0088 Replay Passcode:7254091 Webcast/Webcast Replay link - available through May 15, 2026: https://www.gowebc
Charlotte, North Carolina--(Newsfile Corp. - February 13, 2025) - (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the first quarter of fiscal year ended December 31, 2024. The Company started fiscal 2025 with a historic quarter, achieving sequential revenue growth, positive net income and, although a loss from operations, the first ever quarter of positive non-GAAP Adjusted EBITDA. The Company generated Net Income of $15,000, an approximate $1 million improvement from the prior
Charlotte, North Carolina--(Newsfile Corp. - February 7, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, February 13, 2025, to discuss the company's December 31, 2024 first quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, February 13, 2025, 4:20 p.m. Eastern TimeUSA/Canada:844-763-8274International:647-484-8814Teleconference Replay dial in:USA/Canada:855-669-9658International:412-317-0088Replay Passcode:7970691Webcast/Webcast Replay link - available through March 13, 202
Charlotte, North Carolina--(Newsfile Corp. - January 3, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated December 31, 2024, notifying the Company that it is no longer in compliance with an additional NYSE American continued listing standard. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(i) of the NYSE Amer
Finishes the year with a stronger cash position.Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the full fiscal year ended September 30, 2024. For Fiscal 2024, we continued to make strong progress on our turnaround. The Company incurred a loss from operations of only $3.3 million, or a $19.1 million year-over-year improvement from the $22.9 million loss in the prior year. This is the second consecutive
Live Leadership Updates
Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs and emerging THC-infused seltzer brand Herbal Oasis announced today that at the Company's annual meeting of shareholders held on April 10, 2025, that its Common Stock holders and 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") holders approved the automatic conversion (the "Conversion") of shares of the Company's Preferred Stock into shares of the Comp
Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE:YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency.As a brand that's renowned for its commitment to quality and innovation, cbdMD's comprehensive line of products spans across various categories and caters to a diverse range of consumer needs. By partnering with Dr. Vega, a highly qualified and passi
Charlotte, North Carolina--(Newsfile Corp. - January 11, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the appointment of Shannon Charles as Chief Marketing Officer. Shannon is a veteran in health and wellness with over a decade of success in the Natural Product Industry. She has a proven record in driving growth across B&M retail, warehouse club stores, ecommerce, as well as international markets. Shannon's leadership has supported the successful brand stories of Naturade, NeoCell, and NutraNext, which the latter was ultimately acquired by The Clorox Co during her tenure. "We are thrilled to h
Martin Sumichrast resigns as CEO, Board MemberCharlotte, North Carolina--(Newsfile Corp. - June 13, 2022) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), announced today that Martin Sumichrast has resigned as CEO and member of the Board of Directors, effective immediately. Board member Scott Stephen was named Board Chair and board member Scott Coffman, former co-CEO and the operating company founder, will consult with the Board of Directors in leading the company until a new CEO is named."We appreciate the years of service that Marty has given to our Company since its founding. However, we believe it is in the best interest of cbdMD, our employees, and our investors for him to step down." said Step
SCOTTSDALE, AZ / ACCESSWIRE / June 3, 2021 / Today CBD Life Sciences (OTC:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. is proud to announce that they have appointed Matthew McGee to serve as Chief Marketing Officer of the Company."I am over the top excited to assume the role of Chief Marketing Officer of CBD Life Sciences Inc," Mr. McGee said. "I look forward to growing the current success that CBD Life Sciences has achieved. I couldn't be anymore thankful for this wonderful opportunity, and I look forward to grow the company further, expand sales and bring in more revenue along with more customers as I have already started developing an amazingly effective strategic plan t
This live feed shows all institutional transactions in real time.
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)